Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Jul 31, 2025 | (Q2)Apr 30, 2025 | (Q1)Jan 31, 2025 | (FY)Oct 31, 2024 | (Q4)Oct 31, 2024 | (Q3)Jul 31, 2024 | (Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | (FY)Oct 31, 2023 | (Q4)Oct 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | 0.00%2.25K | 0.00%2.25K | ||||||||
| Gross profit | 0.00%-2.25K | 0.00%-2.25K | ||||||||
| Operating expense | -55.93%96.11K | 76.92%436.84K | 126.31%82.71K | 219.83%1.79M | 773.65%1.28M | -28.07%218.08K | 247.92%246.92K | -2.14%36.55K | 144.74%558.57K | 104.31%147.07K |
| Selling and administrative expenses | -52.75%21.83K | -16.11%167.18K | 13.31%10.34K | 33.57%241.91K | -127.65%-12.7K | -60.45%46.19K | 1,526.86%199.29K | 48.45%9.12K | 249.32%181.11K | 5.82%45.93K |
| -General and administrative expense | -52.75%21.83K | -16.11%167.18K | 13.31%10.34K | 33.57%241.91K | -127.65%-12.7K | -60.45%46.19K | 1,526.86%199.29K | 48.45%9.12K | 249.32%181.11K | 5.82%45.93K |
| Other operating expenses | -56.78%74.28K | 466.15%269.66K | 163.89%72.38K | 309.19%1.54M | 1,182.90%1.3M | -7.78%171.89K | -18.88%47.63K | -12.11%27.43K | 114.00%377.46K | 253.83%101.15K |
| Operating profit | 55.93%-96.11K | -76.92%-436.84K | -126.31%-82.71K | -219.83%-1.79M | -815.68%-1.28M | 28.60%-218.08K | -237.23%-246.92K | 7.70%-36.55K | -139.23%-558.57K | -89.02%-140.32K |
| Net non-operating interest income (expenses) | ||||||||||
| Other net income (expenses) | ||||||||||
| Income before tax | 55.93%-96.11K | -76.92%-436.84K | -126.31%-82.71K | -219.83%-1.79M | -815.68%-1.28M | 28.60%-218.08K | -237.23%-246.92K | 7.70%-36.55K | -139.23%-558.57K | -89.02%-140.32K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 55.93%-96.11K | -76.92%-436.84K | -126.31%-82.71K | -219.83%-1.79M | -815.68%-1.28M | 28.60%-218.08K | -237.23%-246.92K | 7.70%-36.55K | -139.23%-558.57K | -89.02%-140.32K |
| Net income continuous operations | 55.93%-96.11K | -76.92%-436.84K | -126.31%-82.71K | -219.83%-1.79M | -815.68%-1.28M | 28.60%-218.08K | -237.23%-246.92K | 7.70%-36.55K | -139.23%-558.57K | -89.02%-140.32K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 55.93%-96.11K | -76.92%-436.84K | -126.31%-82.71K | -219.83%-1.79M | -815.68%-1.28M | 28.60%-218.08K | -237.23%-246.92K | 7.70%-36.55K | -139.23%-558.57K | -89.02%-140.32K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 55.93%-96.11K | -76.92%-436.84K | -126.31%-82.71K | -219.83%-1.79M | -815.68%-1.28M | 28.60%-218.08K | -237.23%-246.92K | 7.70%-36.55K | -139.23%-558.57K | -89.02%-140.32K |
| Diluted earnings per share | 0 | 0.00%-0.01 | 0 | -75.00%-0.07 | -500.00%-0.06 | 66.67%-0.01 | -149.56%-0.01 | 0 | -200.23%-0.04 | -136.07%-0.01 |
| Basic earnings per share | 0 | 0.00%-0.01 | 0 | -75.00%-0.07 | -500.00%-0.06 | 66.67%-0.01 | -149.56%-0.01 | 0 | -200.23%-0.04 | -136.07%-0.01 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.